
Taylor, CFO of Recursion Pharmaceuticals, sold $89k in shares
Source link
Provexis reported lower half-year earnings amid production delays
Provexis reported lower half-year earnings amid production delays Source link

Taylor, CFO of Recursion Pharmaceuticals, sold $89k in shares
Source link
Provexis reported lower half-year earnings amid production delays Source link
RLX Technology Extends $500 Million Share Repurchase Program Through 2027 Source link